25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

SAMRAT PHARMACHEM LTD.-$
Buy, Hold or Sell?

Let's analyze SAMRAT PHARMACHEM LTD.-$ together

I guess you are interested in SAMRAT PHARMACHEM LTD.-$. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of SAMRAT PHARMACHEM LTD.-$. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about SAMRAT PHARMACHEM LTD.-$

I send you an email if I find something interesting about SAMRAT PHARMACHEM LTD.-$.

1. Quick Overview

1.1. Quick analysis of SAMRAT PHARMACHEM LTD.-$ (30 sec.)










1.2. What can you expect buying and holding a share of SAMRAT PHARMACHEM LTD.-$? (30 sec.)

How much money do you get?

How much money do you get?
INR0.05
When do you have the money?
1 year
How often do you get paid?
33.3%

What is your share worth?

Current worth
INR210.37
Expected worth in 1 year
INR234.37
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR28.00
Return On Investment
6.3%

For what price can you sell your share?

Current Price per Share
INR444.05
Expected price per share
INR378.75 - INR625.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of SAMRAT PHARMACHEM LTD.-$ (5 min.)




Live pricePrice per Share (EOD)
INR444.05
Intrinsic Value Per Share
INR221.69 - INR453.15
Total Value Per Share
INR432.06 - INR663.52

2.2. Growth of SAMRAT PHARMACHEM LTD.-$ (5 min.)




Is SAMRAT PHARMACHEM LTD.-$ growing?

Current yearPrevious yearGrowGrow %
How rich?$7.7m$7.5m$220.5k2.9%

How much money is SAMRAT PHARMACHEM LTD.-$ making?

Current yearPrevious yearGrowGrow %
Making money$257.3k$1.9m-$1.7m-669.0%
Net Profit Margin0.8%5.4%--

How much money comes from the company's main activities?

2.3. Financial Health of SAMRAT PHARMACHEM LTD.-$ (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of SAMRAT PHARMACHEM LTD.-$?

Welcome investor! SAMRAT PHARMACHEM LTD.-$'s management wants to use your money to grow the business. In return you get a share of SAMRAT PHARMACHEM LTD.-$.

First you should know what it really means to hold a share of SAMRAT PHARMACHEM LTD.-$. And how you can make/lose money.

Speculation

The Price per Share of SAMRAT PHARMACHEM LTD.-$ is INR444.05. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of SAMRAT PHARMACHEM LTD.-$.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in SAMRAT PHARMACHEM LTD.-$, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR210.37. Based on the TTM, the Book Value Change Per Share is INR6.00 per quarter. Based on the YOY, the Book Value Change Per Share is INR52.83 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR1.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of SAMRAT PHARMACHEM LTD.-$.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.080.0%0.080.0%0.640.1%0.350.1%0.300.1%
Usd Book Value Change Per Share0.070.0%0.070.0%0.630.1%0.350.1%0.420.1%
Usd Dividend Per Share0.010.0%0.010.0%0.010.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.080.0%0.080.0%0.640.1%0.350.1%0.420.1%
Usd Price Per Share3.97-3.97-4.42-3.30-2.90-
Price to Earnings Ratio47.64-47.64-6.89-15.10-15.09-
Price-to-Total Gains Ratio47.64-47.64-6.89-15.10-12.77-
Price to Book Ratio1.59-1.59-1.82-1.76-1.65-
Price-to-Total Gains Ratio47.64-47.64-6.89-15.10-12.77-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.284195
Number of shares189
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share0.070.35
Usd Total Gains Per Share0.080.35
Gains per Quarter (189 shares)15.7466.31
Gains per Year (189 shares)62.97265.25
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1954534262255
2181081167523520
32716217911785785
4362162421410471050
5452703051813081315
6543243682215701580
7633784312518321845
8724324942920932110
9814865573223552375
10905406203626162640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%2.00.03.040.0%2.00.04.033.3%2.00.04.033.3%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of SAMRAT PHARMACHEM LTD.-$ compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--6.0006.0000%52.826-89%29.084-79%35.061-83%
Book Value Per Share--210.367210.3670%204.367+3%148.171+42%134.301+57%
Current Ratio--1.8181.8180%1.869-3%1.759+3%1.748+4%
Debt To Asset Ratio--0.4660.4660%0.456+2%0.487-4%0.490-5%
Debt To Equity Ratio--0.8730.8730%0.839+4%0.971-10%0.977-11%
Dividend Per Share--1.0001.0000%1.0000%0.400+150%0.333+200%
Eps--6.9996.9990%53.826-87%29.484-76%25.398-72%
Free Cash Flow Per Share--28.30528.3050%-34.944+223%8.446+235%8.159+247%
Free Cash Flow To Equity Per Share--28.30528.3050%-34.944+223%8.446+235%6.044+368%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--453.150--------
Intrinsic Value_10Y_min--221.690--------
Intrinsic Value_1Y_max--21.810--------
Intrinsic Value_1Y_min--12.039--------
Intrinsic Value_3Y_max--83.516--------
Intrinsic Value_3Y_min--45.201--------
Intrinsic Value_5Y_max--166.905--------
Intrinsic Value_5Y_min--88.002--------
Market Cap--1030260465.0001030260465.0000%1146587670.000-10%856001385.000+20%751775505.000+37%
Net Profit Margin--0.0080.0080%0.054-86%0.040-81%0.036-78%
Operating Margin----0%-0%0.010-100%0.013-100%
Operating Ratio--1.9541.9540%1.820+7%1.862+5%1.871+4%
Pb Ratio2.111+25%1.5851.5850%1.816-13%1.756-10%1.655-4%
Pe Ratio63.441+25%47.64047.6400%6.894+591%15.100+216%15.086+216%
Price Per Share444.050+25%333.450333.4500%371.100-10%277.050+20%243.317+37%
Price To Free Cash Flow Ratio15.688+25%11.78111.7810%-10.620+190%4.975+137%5.996+96%
Price To Total Gains Ratio63.438+25%47.63847.6380%6.894+591%15.099+215%12.774+273%
Quick Ratio--1.2301.2300%0.972+27%1.080+14%1.082+14%
Return On Assets--0.0180.0180%0.143-88%0.106-83%0.095-81%
Return On Equity--0.0330.0330%0.263-87%0.204-84%0.182-82%
Total Gains Per Share--7.0007.0000%53.826-87%29.484-76%35.394-80%
Usd Book Value--7734643.0007734643.0000%7514052.700+3%5447881.268+42%4937895.048+57%
Usd Book Value Change Per Share--0.0710.0710%0.629-89%0.346-79%0.417-83%
Usd Book Value Per Share--2.5032.5030%2.432+3%1.763+42%1.598+57%
Usd Dividend Per Share--0.0120.0120%0.0120%0.005+150%0.004+200%
Usd Eps--0.0830.0830%0.641-87%0.351-76%0.302-72%
Usd Free Cash Flow--1040690.7001040690.7000%-1284795.400+223%310529.350+235%299984.004+247%
Usd Free Cash Flow Per Share--0.3370.3370%-0.416+223%0.101+235%0.097+247%
Usd Free Cash Flow To Equity Per Share--0.3370.3370%-0.416+223%0.101+235%0.072+368%
Usd Market Cap--12260099.53412260099.5340%13644393.273-10%10186416.482+20%8946128.510+37%
Usd Price Per Share5.284+25%3.9683.9680%4.416-10%3.297+20%2.895+37%
Usd Profit--257349.400257349.4000%1979029.500-87%1084038.840-76%933821.312-72%
Usd Revenue--33508162.80033508162.8000%36966862.100-9%26902533.876+25%24622432.239+36%
Usd Total Gains Per Share--0.0830.0830%0.641-87%0.351-76%0.421-80%
 EOD+2 -4MRQTTM+0 -0YOY+12 -205Y+20 -1510Y+20 -15

3.3 Fundamental Score

Let's check the fundamental score of SAMRAT PHARMACHEM LTD.-$ based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1563.441
Price to Book Ratio (EOD)Between0-12.111
Net Profit Margin (MRQ)Greater than00.008
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.230
Current Ratio (MRQ)Greater than11.818
Debt to Asset Ratio (MRQ)Less than10.466
Debt to Equity Ratio (MRQ)Less than10.873
Return on Equity (MRQ)Greater than0.150.033
Return on Assets (MRQ)Greater than0.050.018
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of SAMRAT PHARMACHEM LTD.-$ based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.916
Ma 20Greater thanMa 50467.435
Ma 50Greater thanMa 100516.346
Ma 100Greater thanMa 200453.276
OpenGreater thanClose442.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About SAMRAT PHARMACHEM LTD.-$

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit SAMRAT PHARMACHEM LTD.-$ earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare SAMRAT PHARMACHEM LTD.-$ to the  industry mean.
  • A Net Profit Margin of 0.8% means that ₹0.01 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SAMRAT PHARMACHEM LTD.-$:

  • The MRQ is 0.8%. The company is not making a profit/loss.
  • The TTM is 0.8%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.8%0.0%
TTM0.8%YOY5.4%-4.6%
TTM0.8%5Y4.0%-3.2%
5Y4.0%10Y3.6%+0.4%
4.3.1.2. Return on Assets

Shows how efficient SAMRAT PHARMACHEM LTD.-$ is using its assets to generate profit.

  • Above 5% is considered healthy but always compare SAMRAT PHARMACHEM LTD.-$ to the  industry mean.
  • 1.8% Return on Assets means that SAMRAT PHARMACHEM LTD.-$ generated ₹0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SAMRAT PHARMACHEM LTD.-$:

  • The MRQ is 1.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.8%TTM1.8%0.0%
TTM1.8%YOY14.3%-12.5%
TTM1.8%5Y10.6%-8.8%
5Y10.6%10Y9.5%+1.1%
4.3.1.3. Return on Equity

Shows how efficient SAMRAT PHARMACHEM LTD.-$ is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare SAMRAT PHARMACHEM LTD.-$ to the  industry mean.
  • 3.3% Return on Equity means SAMRAT PHARMACHEM LTD.-$ generated ₹0.03 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SAMRAT PHARMACHEM LTD.-$:

  • The MRQ is 3.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.3%TTM3.3%0.0%
TTM3.3%YOY26.3%-23.0%
TTM3.3%5Y20.4%-17.0%
5Y20.4%10Y18.2%+2.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of SAMRAT PHARMACHEM LTD.-$.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient SAMRAT PHARMACHEM LTD.-$ is operating .

  • Measures how much profit SAMRAT PHARMACHEM LTD.-$ makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare SAMRAT PHARMACHEM LTD.-$ to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SAMRAT PHARMACHEM LTD.-$:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y1.0%-1.0%
5Y1.0%10Y1.3%-0.3%
4.3.2.2. Operating Ratio

Measures how efficient SAMRAT PHARMACHEM LTD.-$ is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.95 means that the operating costs are ₹1.95 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of SAMRAT PHARMACHEM LTD.-$:

  • The MRQ is 1.954. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.954. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.954TTM1.9540.000
TTM1.954YOY1.820+0.134
TTM1.9545Y1.862+0.092
5Y1.86210Y1.871-0.009
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of SAMRAT PHARMACHEM LTD.-$.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if SAMRAT PHARMACHEM LTD.-$ is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.82 means the company has ₹1.82 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of SAMRAT PHARMACHEM LTD.-$:

  • The MRQ is 1.818. The company is able to pay all its short-term debts. +1
  • The TTM is 1.818. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.818TTM1.8180.000
TTM1.818YOY1.869-0.051
TTM1.8185Y1.759+0.060
5Y1.75910Y1.748+0.011
4.4.3.2. Quick Ratio

Measures if SAMRAT PHARMACHEM LTD.-$ is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare SAMRAT PHARMACHEM LTD.-$ to the  industry mean.
  • A Quick Ratio of 1.23 means the company can pay off ₹1.23 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SAMRAT PHARMACHEM LTD.-$:

  • The MRQ is 1.230. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.230. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.230TTM1.2300.000
TTM1.230YOY0.972+0.258
TTM1.2305Y1.080+0.150
5Y1.08010Y1.082-0.003
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of SAMRAT PHARMACHEM LTD.-$.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of SAMRAT PHARMACHEM LTD.-$ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare SAMRAT PHARMACHEM LTD.-$ to industry mean.
  • A Debt to Asset Ratio of 0.47 means that SAMRAT PHARMACHEM LTD.-$ assets are financed with 46.6% credit (debt) and the remaining percentage (100% - 46.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SAMRAT PHARMACHEM LTD.-$:

  • The MRQ is 0.466. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.466. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.466TTM0.4660.000
TTM0.466YOY0.456+0.010
TTM0.4665Y0.487-0.021
5Y0.48710Y0.490-0.002
4.5.4.2. Debt to Equity Ratio

Measures if SAMRAT PHARMACHEM LTD.-$ is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare SAMRAT PHARMACHEM LTD.-$ to the  industry mean.
  • A Debt to Equity ratio of 87.3% means that company has ₹0.87 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SAMRAT PHARMACHEM LTD.-$:

  • The MRQ is 0.873. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.873. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.873TTM0.8730.000
TTM0.873YOY0.839+0.033
TTM0.8735Y0.971-0.098
5Y0.97110Y0.977-0.006
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings SAMRAT PHARMACHEM LTD.-$ generates.

  • Above 15 is considered overpriced but always compare SAMRAT PHARMACHEM LTD.-$ to the  industry mean.
  • A PE ratio of 47.64 means the investor is paying ₹47.64 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SAMRAT PHARMACHEM LTD.-$:

  • The EOD is 63.441. Based on the earnings, the company is expensive. -2
  • The MRQ is 47.640. Based on the earnings, the company is overpriced. -1
  • The TTM is 47.640. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD63.441MRQ47.640+15.801
MRQ47.640TTM47.6400.000
TTM47.640YOY6.894+40.745
TTM47.6405Y15.100+32.540
5Y15.10010Y15.086+0.013
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of SAMRAT PHARMACHEM LTD.-$:

  • The EOD is 15.688. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 11.781. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 11.781. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD15.688MRQ11.781+3.907
MRQ11.781TTM11.7810.000
TTM11.781YOY-10.620+22.401
TTM11.7815Y4.975+6.806
5Y4.97510Y5.996-1.021
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of SAMRAT PHARMACHEM LTD.-$ is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 1.59 means the investor is paying ₹1.59 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of SAMRAT PHARMACHEM LTD.-$:

  • The EOD is 2.111. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.585. Based on the equity, the company is underpriced. +1
  • The TTM is 1.585. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.111MRQ1.585+0.526
MRQ1.585TTM1.5850.000
TTM1.585YOY1.816-0.231
TTM1.5855Y1.756-0.171
5Y1.75610Y1.655+0.101
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets1,217,358
Total Liabilities567,388
Total Stockholder Equity649,970
 As reported
Total Liabilities 567,388
Total Stockholder Equity+ 649,970
Total Assets = 1,217,358

Assets

Total Assets1,217,358
Total Current Assets1,025,674
Long-term Assets191,684
Total Current Assets
Cash And Cash Equivalents 96,675
Short-term Investments 880
Net Receivables 692,777
Inventory 206,769
Other Current Assets 28,573
Total Current Assets  (as reported)1,025,674
Total Current Assets  (calculated)1,025,674
+/-0
Long-term Assets
Property Plant Equipment 107,157
Intangible Assets 66
Long-term Assets Other 6,053
Long-term Assets  (as reported)191,684
Long-term Assets  (calculated)113,276
+/- 78,408

Liabilities & Shareholders' Equity

Total Current Liabilities564,026
Long-term Liabilities3,362
Total Stockholder Equity649,970
Total Current Liabilities
Short Long Term Debt 84,547
Accounts payable 476,684
Other Current Liabilities 1,011
Total Current Liabilities  (as reported)564,026
Total Current Liabilities  (calculated)562,242
+/- 1,784
Long-term Liabilities
Long-term Liabilities  (as reported)3,362
Long-term Liabilities  (calculated)0
+/- 3,362
Total Stockholder Equity
Total Stockholder Equity (as reported)649,970
Total Stockholder Equity (calculated)0
+/- 649,970
Other
Capital Stock30,897
Common Stock Shares Outstanding 3,090
Net Invested Capital 734,517
Net Working Capital 461,648



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
402,266
583,486
573,965
846,120
1,161,507
1,217,358
1,217,3581,161,507846,120573,965583,486402,26600
   > Total Current Assets 
282,966
332,656
327,586
496,804
473,238
712,611
986,153
1,025,674
1,025,674986,153712,611473,238496,804327,586332,656282,966
       Cash And Cash Equivalents 
0
0
22,462
11,719
25,058
147,050
118,621
96,675
96,675118,621147,05025,05811,71922,46200
       Short-term Investments 
0
0
10
10
10
100
139
880
88013910010101000
       Net Receivables 
121,853
222,481
211,875
278,362
330,054
435,746
512,371
692,777
692,777512,371435,746330,054278,362211,875222,481121,853
       Inventory 
70,214
68,462
79,296
187,674
113,999
124,160
325,278
206,769
206,769325,278124,160113,999187,67479,29668,46270,214
       Other Current Assets 
65,964
780
13,773
19,040
367
200
50
28,573
28,5735020036719,04013,77378065,964
   > Long-term Assets 
0
0
74,680
86,681
100,726
133,509
175,354
191,684
191,684175,354133,509100,72686,68174,68000
       Property Plant Equipment 
71,682
69,596
68,354
82,623
93,939
99,772
106,950
107,157
107,157106,95099,77293,93982,62368,35469,59671,682
       Intangible Assets 
0
0
276
39
95
85
75
66
667585953927600
       Long-term Assets Other 
0
0
960
0
-3
1
497
6,053
6,0534971-3096000
> Total Liabilities 
0
0
201,597
340,449
277,596
377,903
530,074
567,388
567,388530,074377,903277,596340,449201,59700
   > Total Current Liabilities 
191,043
210,238
193,289
339,001
273,271
373,294
527,533
564,026
564,026527,533373,294273,271339,001193,289210,238191,043
       Short Long Term Debt 
0
0
62,201
94,088
87,937
75,197
186,593
84,547
84,547186,59375,19787,93794,08862,20100
       Accounts payable 
72,135
103,897
125,287
231,461
176,602
233,916
318,801
476,684
476,684318,801233,916176,602231,461125,287103,89772,135
       Other Current Liabilities 
56,151
15,031
4,352
12,184
1,709
8,899
493
1,011
1,0114938,8991,70912,1844,35215,03156,151
   > Long-term Liabilities 
0
0
8,307
1,448
4,325
4,609
2,541
3,362
3,3622,5414,6094,3251,4488,30700
       Deferred Long Term Liability 
646
814
960
0
0
0
0
0
00000960814646
> Total Stockholder Equity
0
0
200,669
243,037
296,369
468,217
631,433
649,970
649,970631,433468,217296,369243,037200,66900
   Common Stock
30,897
30,897
30,897
30,897
0
0
0
0
000030,89730,89730,89730,897
   Retained Earnings Total Equity00000000
   Accumulated Other Comprehensive Income 00000000
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 00000000



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue2,815,812
Cost of Revenue-2,703,181
Gross Profit112,631112,631
 
Operating Income (+$)
Gross Profit112,631
Operating Expense-2,797,586
Operating Income18,226-2,684,955
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense2,797,5860
 
Net Interest Income (+$)
Interest Income0
Interest Expense-6,870
Other Finance Cost-0
Net Interest Income-6,870
 
Pretax Income (+$)
Operating Income18,226
Net Interest Income-6,870
Other Non-Operating Income Expenses0
Income Before Tax (EBT)25,20218,226
EBIT - interestExpense = -6,870
21,626
28,496
Interest Expense6,870
Earnings Before Interest and Taxes (EBIT)032,072
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax25,202
Tax Provision-3,576
Net Income From Continuing Ops21,62621,626
Net Income21,626
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net06,870
 

Technical Analysis of SAMRAT PHARMACHEM LTD.-$
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of SAMRAT PHARMACHEM LTD.-$. The general trend of SAMRAT PHARMACHEM LTD.-$ is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine SAMRAT PHARMACHEM LTD.-$'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of SAMRAT PHARMACHEM LTD.-$.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 511.00 < 579.85 < 625.00.

The bearish price targets are: 435.00 > 428.57 > 378.75.

Tweet this
SAMRAT PHARMACHEM LTD.-$ Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of SAMRAT PHARMACHEM LTD.-$. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

SAMRAT PHARMACHEM LTD.-$ Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of SAMRAT PHARMACHEM LTD.-$. The current macd is -15.06860975.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the SAMRAT PHARMACHEM LTD.-$ price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for SAMRAT PHARMACHEM LTD.-$. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the SAMRAT PHARMACHEM LTD.-$ price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
SAMRAT PHARMACHEM LTD.-$ Daily Moving Average Convergence/Divergence (MACD) ChartSAMRAT PHARMACHEM LTD.-$ Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of SAMRAT PHARMACHEM LTD.-$. The current adx is 15.69.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell SAMRAT PHARMACHEM LTD.-$ shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
SAMRAT PHARMACHEM LTD.-$ Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of SAMRAT PHARMACHEM LTD.-$. The current sar is 496.58.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
SAMRAT PHARMACHEM LTD.-$ Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of SAMRAT PHARMACHEM LTD.-$. The current rsi is 37.92. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
SAMRAT PHARMACHEM LTD.-$ Daily Relative Strength Index (RSI) ChartSAMRAT PHARMACHEM LTD.-$ Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of SAMRAT PHARMACHEM LTD.-$. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the SAMRAT PHARMACHEM LTD.-$ price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
SAMRAT PHARMACHEM LTD.-$ Daily Stochastic Oscillator ChartSAMRAT PHARMACHEM LTD.-$ Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of SAMRAT PHARMACHEM LTD.-$. The current cci is -109.68508616.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
SAMRAT PHARMACHEM LTD.-$ Daily Commodity Channel Index (CCI) ChartSAMRAT PHARMACHEM LTD.-$ Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of SAMRAT PHARMACHEM LTD.-$. The current cmo is -30.73822171.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
SAMRAT PHARMACHEM LTD.-$ Daily Chande Momentum Oscillator (CMO) ChartSAMRAT PHARMACHEM LTD.-$ Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of SAMRAT PHARMACHEM LTD.-$. The current willr is -89.92612492.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
SAMRAT PHARMACHEM LTD.-$ Daily Williams %R ChartSAMRAT PHARMACHEM LTD.-$ Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of SAMRAT PHARMACHEM LTD.-$.

SAMRAT PHARMACHEM LTD.-$ Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of SAMRAT PHARMACHEM LTD.-$. The current atr is 27.28.

SAMRAT PHARMACHEM LTD.-$ Daily Average True Range (ATR) ChartSAMRAT PHARMACHEM LTD.-$ Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of SAMRAT PHARMACHEM LTD.-$. The current obv is -49,924.

SAMRAT PHARMACHEM LTD.-$ Daily On-Balance Volume (OBV) ChartSAMRAT PHARMACHEM LTD.-$ Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of SAMRAT PHARMACHEM LTD.-$. The current mfi is 34.10.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
SAMRAT PHARMACHEM LTD.-$ Daily Money Flow Index (MFI) ChartSAMRAT PHARMACHEM LTD.-$ Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for SAMRAT PHARMACHEM LTD.-$.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-27MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

SAMRAT PHARMACHEM LTD.-$ Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of SAMRAT PHARMACHEM LTD.-$ based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.916
Ma 20Greater thanMa 50467.435
Ma 50Greater thanMa 100516.346
Ma 100Greater thanMa 200453.276
OpenGreater thanClose442.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of SAMRAT PHARMACHEM LTD.-$ with someone you think should read this too:
  • Are you bullish or bearish on SAMRAT PHARMACHEM LTD.-$? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about SAMRAT PHARMACHEM LTD.-$? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about SAMRAT PHARMACHEM LTD.-$

I send you an email if I find something interesting about SAMRAT PHARMACHEM LTD.-$.


Comments

How you think about this?

Leave a comment

Stay informed about SAMRAT PHARMACHEM LTD.-$.

Receive notifications about SAMRAT PHARMACHEM LTD.-$ in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.